Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series

Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series

Abstract Background Tocilizumab is a monoclonal antibody directed against the interleukin-6 receptor, which is approved for the treatment of moderate-to-severe rheumatoid arthritis. Authors have found that it prevents lung and subcutaneous nodulosis in patients with rheumatoid arthritis but, to the...

Full description

Bibliographic Details
Main Authors: Rossella Talotta, Fabiola Atzeni, Alberto Batticciotto, Maria Chiara Ditto, Maria Chiara Gerardi, Piercarlo Sarzi-Puttini
Format: Article
Language:English
Published: BMC 2018-06-01
Series:Journal of Medical Case Reports
Subjects:
Rheumatic nodulosis
Tocilizumab
Rheumatoid arthritis
Online Access:http://link.springer.com/article/10.1186/s13256-018-1687-y

Similar Items

Similar Items